Pluri (PLUR) Stock Analysis: AI Score & Alternative Data
Demand signals are heating up for Pluri
Is Pluri a buy right now? The alternative data says hold. This PLUR stock analysis is built on the 25+ alternative data signals AltIndex tracks on Pluri every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 40/100: a Hold. The stock trades at $0.95 with a $12M market cap.
The data leans positive over the past 90 days — web traffic up 40.1% to 3K monthly visits — but the move hasn’t been broad enough to lift PLUR into buy territory yet.
PLUR’s broader alt-data profile also covers headcount (249 employees, according to LinkedIn), and X followers (3K). Every signal links to its own page with full history, the PLUR technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on PLUR is just below.
Pluri AI Stock Analysis
Pluri is a company involved in innovative ventures which leverages its expertise in science and technology to drive growth. The company appears to be making strides in its sector, but faces stiff competition and volatility in its financial health.
Analysis generated October 2, 2026.
Recent Pluri Stock Alerts
|
Pluri | October 9 Price is down by -15% in the last 24h. |
|
Pluri | October 7 Price is down by -14.1% in the last 24h. |
|
Pluri | September 29 Price is up by 7.2% in the last 24h. |
|
Pluri | September 28 Price is up by 6.4% in the last 24h. |
Pluri Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 3K | 40.1% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 249 | 2.0% | |
| Wikipedia Views | 2 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 2 | 100.0% | |
| Stocktwits Mentions | 3 | 200.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 6K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 3K | 0.6% | |
| Youtube Subscribers | 410 | 0% |
About Pluri (PLUR)
Pluri Inc., a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions.
| Price | $0.95 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $12M |
| Year Range | $1 – $5 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Pluri News
View more → |
Where To Watch ‘Pluribus’ Online: How To Stream This 2026 Emmy-Winner For FreeSeptember 15 - Decider |
Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest InMay 30 - Yahoo Entertainment |
|
Pluri announces additional $2.5M investment from Alejandro WeinsteinMarch 26 - Thefly.com |
|
 |
Pluri secures global IP position with CNIPA for immune cell expansionFebruary 18 - Thefly.com |
Pluri Subsidiary Puri Biotech Secures Patent Covering 3D Immune Cell Expansion TechFebruary 17 - Benzinga |
|
See Pluri’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for PLUR, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEPluri Earnings & Financial Performance
View all earnings →Pluri Insider Trading Activity
View all →| Manieu Alexandre Weinstein filed to sell 452,702 shares at $0.0. Apr 28 '25 |
| Manieu Alexandre Weinstein filed to sell 931,246 shares at $0.0. Apr 28 '25 |
| Manieu Alexandre Weinstein filed to sell 452,702 shares at $0.0. Apr 28 '25 |
| Aberman Zami filed to sell 1,491,973 shares at $0.0. Dec 20 '22 |
| Aberman Zami filed to sell 91,756 shares at $0.0. Feb 10 '22 |
Pluri Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Pluri
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Lantern PharmaLTRN |
$0.81 2.1% | $12M | 45 |
 |
Intensity TherapeuticsINTS |
$3.63 1.4% | $12M | 50 |
 |
Phio PharmaceuticalsPHIO |
$0.98 0.6% | $11M | 55 |
 |
Kiora PharmaceuticalsKPRX |
$2.54 0.4% | $11M | 57 |
 |
Tempest TherapeuticsTPST |
$0.76 1.3% | $13M | 44 |
Explore Pluri Data
Frequently Asked Questions: Pluri (PLUR)
Pluri has an AltIndex AI Score of 40/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
40/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Pluri (PLUR) stock is $0.95 with a market cap of $12M.
As of today, Pluri’s PE (Price to Earnings) ratio is —.
View the latest Pluri insider transactions to see recent buying and selling activity by company executives and directors.
Check the Pluri congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The PLUR stock price chart above shows Pluri’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Pluri technical analysis for RSI, moving averages, and more.
See the stocks similar to Pluri section on this page for companies in the same industry ranked by market cap and AI Score.
